ScreenerHero
NPTHNeuPath Health Inc.
TSXV · CA · Healthcare · Medical Care Facilities · neupath.com
0.5700CAD-1.72%Mkt Cap: 23.32M $P/E: 57.00

NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, m…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$90.30BUSDP/E 13.7
FRE
Fresenius SE & Co. KGaA
$28.53BUSDP/E 16.8
THC
Tenet Healthcare Corporation
$21.62BUSDP/E 10.4
FME
Fresenius Medical Care AG
$11.72BUSDP/E 12.1
EHC
Encompass Health Corporation
$12.01BUSDP/E 20.3
DVA
DaVita Inc.
$11.38BUSDP/E 15.0
ENSG
The Ensign Group, Inc.
$10.64BUSDP/E 28.6
UHS
Universal Health Services, Inc. Class B
$10.16BUSDP/E 7.0
PACS
PACS Group Inc.
$7.01BUSDP/E 25.9
CHE
Chemed Corporation
$7.00BUSDP/E 26.9
LFST
LifeStance Health Group Inc. Common Stock
$4.90BUSDP/E 98.7
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.43BUSDP/E 22.4
MCOV-B
Medicover AB (publ)
$3.50BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.67BUSDP/E 26.3
OPCH
Option Care Health, Inc.
$3.50BUSDP/E 17.7
BKD
Brookdale Senior Living Inc.
$2.89BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.4
EMEIS
EMEIS
$2.45BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.55BUSD
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
$2.41BUSDP/E 36.5

Key Statistics

Company
Market Cap23.32M $
Enterprise Value31.03M $
Revenue (TTM)64.79M $
Gross Profit12.08M $
Net Income (TTM)-522.16K $
Revenue/Share1.151 USD
Last Price0.5700 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees152
CountryCA
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)57.00
P/E (Forward)5.70
PEG—
EV/EBITDA12.73
EV/Revenue0.48
P/S0.37
P/B1.53
EPS (TTM)0.01
EPS (Forward)0.10
52W Range
0.270073% of range0.6800
52W High0.6800 CAD
52W Low0.2700 CAD
Profitability
Gross Margin19.03%
Oper. Margin4.43%
EBITDA Margin3.76%
Profit Margin-0.82%
ROE-3.48%
ROA-1.59%
Growth
Revenue Growth-1.70%
Earnings Growth537.10%
Cash Flow & Leverage
Operating CF2.92M $
CapEx (TTM)628.49K $
FCF Margin1.94%
FCF Yield5.40%
Net Debt7.03M $
Net Debt/EBITDA2.88
Balance Sheet
Debt/Equity0.64
Current Ratio1.19
Quick Ratio1.14
Book Value/Sh0.3720 CAD
Cash/Share0.0620 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 6, 2020
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.7650 CAD
Upside (mean)+34.2%
Target Range0.5800 CAD – 0.9500 CAD
CAD0.5800+34.2% to meanCAD0.9500
# Analysts2
Ownership
Shares Out.56.98M
Float49.08M
Insiders2.87%
Institutions10.83%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short4.38K
Short (prev mo.)6.33K
Technical
SMA 500.6166 (-7.6%)
SMA 2000.5273 (+8.1%)
Beta1.07
S&P 52W Chg18.16%
Avg Vol (30d)58.52K
Avg Vol (10d)60.55K
Technical Indicators
RSI (14)39.9
MACD-0.0077
MACD Signal-0.0035
MACD Hist.-0.0041
BB Upper0.6462 CAD
BB Middle0.6080 CAD
BB Lower0.5698 CAD
BB Width12.56%
ATR (14)0.0263 CAD
Vol Ratio (20d)0.21x